HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Slowly progressive spinocerebellar ataxia with extrapyramidal signs and mild cognitive impairment (SCA21).

Abstract
Spinocerebellar ataxia 21 is a slowly progressive and mild ataxia associated with extrapyramidal signs. Affected subjects exhibit a moderate gait and limb ataxia variably associated with akinesia, tremor, rigidity, hyporeflexia, and mild cognitive impairment. The responsible gene has been assigned to a 19 Mbases interval on chromosome 7p in a single French family. No evidence of significant linkage to this locus was found in 21 other families obtained from the EUROSCA consortium. The locus interval contains several candidate genes that could be responsible for the disease. Direct sequencing of NDUFA4, PHF14, KIAA0960, ARLA4, ETV1, DGKB, HDAC9, FERD3L, ITGB8, and SP4 genes were performed, but all the direct mutation analyses were negative excluding pathogenic mutations associated with the disease. Therefore, the gene responsible for SCA21 remains to be identified.
AuthorsJ Delplanque, D Devos, I Vuillaume, A De Becdelievre, E Vangelder, C A Maurage, K Dujardin, A Destée, B Sablonnière
JournalCerebellum (London, England) (Cerebellum) Vol. 7 Issue 2 Pg. 179-83 ( 2008) ISSN: 1473-4230 [Electronic] United States
PMID18418688 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Nerve Tissue Proteins
  • atrophin-1
Topics
  • Adult
  • Age of Onset
  • Basal Ganglia Diseases (physiopathology, psychology)
  • Chromosome Mapping
  • Cognition Disorders (etiology)
  • DNA Mutational Analysis
  • Disease Progression
  • Female
  • France
  • Genetic Linkage
  • Genotype
  • Humans
  • Male
  • Nerve Tissue Proteins (genetics)
  • Pedigree
  • Phenotype
  • Spinocerebellar Ataxias (physiopathology, psychology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: